{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:25:33Z","timestamp":1793787933160,"version":"4.6.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaci.2026.07.018","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:53Z","timestamp":1786117013000},"page":"1288-1301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond type 2 inflammation: An innate\u2013myeloid axis is linked to recurrence of chronic rhinosinusitis with nasal polyps"],"prefix":"10.1016","volume":"158","author":[{"given":"Tiffany","family":"Dharia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Zawacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan W.","family":"Bergmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Z.","family":"Maxfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Roditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"LeSon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radomir","family":"Kratchmarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5134-6312","authenticated-orcid":false,"given":"Kathleen M.","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.018_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/000348940911800305","article-title":"Assessing the additional disease burden of polyps in chronic rhinosinusitis","volume":"118","author":"Bhattacharyya","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2026.07.018_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.anai.2016.12.012","article-title":"Depression symptoms and lost productivity in chronic rhinosinusitis","volume":"118","author":"Campbell","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/19458924231152671","article-title":"Understanding the CRSwNP patient as whole","volume":"37","author":"Bandi","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.018_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"suppl S29","key":"10.1016\/j.jaci.2026.07.018_bib6","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps, 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2026.07.018_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2026.07.018_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2026.07.018_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030866","article-title":"Long-term clinical outcomes in patients with chronic rhinosinusitis with nasal polyps associated with expanded types of endoscopic sinus surgery","volume":"13","author":"Martin-Jimenez","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2026.07.018_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alr.22369","article-title":"Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2026.07.018_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/lary.26741","article-title":"Revision rates and time to revision following endoscopic sinus surgery: a large database analysis","volume":"128","author":"Stein","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2026.07.018_bib12","first-page":"109","article-title":"Twelve-year long-term postoperative outcomes in patients with chronic rhinosinusitis with nasal polyps","volume":"60","author":"Arancibia","year":"2022","journal-title":"Rhinology"},{"issue":"10209","key":"10.1016\/j.jaci.2026.07.018_bib13","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.018_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2026.07.018_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","author":"Lipworth","year":"20253921178","journal-title":"N Engl J Med"},{"issue":"10482","key":"10.1016\/j.jaci.2026.07.018_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(25)00197-7","article-title":"Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials","volume":"405","author":"Gevaert","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.018_bib18","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jaci.2025.03.011","article-title":"Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps","volume":"155","author":"Kratchmarov","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib19","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.018_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaci.2025.03.029","article-title":"Effects of inflammatory endotypes on disease trajectory in chronic rhinosinusitis with nasal polyps","volume":"156","author":"Dorismond","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.018_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaci.2022.02.029","article-title":"Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps","volume":"150","author":"Bai","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaci.2025.09.031","article-title":"Validation of a risk predictor score for early polyp recurrence in CRSwNP","volume":"157","author":"Bai","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaci.2025.09.023","article-title":"Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps","volume":"157","author":"Oka","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/all.70237","article-title":"Comorbid chronic rhinosinusitis and asthma: shared risk factors and treatment implications\u2014an EAACI Task Force report","volume":"81","author":"Toppila-Salmi","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2500\/ajr.2006.20.2913","article-title":"Medical and surgical considerations in patients with Samter\u2019s triad","volume":"20","author":"McMains","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2026.07.018_bib28","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jaci.2020.02.035","article-title":"IL-5Ralpha marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease","volume":"145","author":"Buchheit","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000348941112000304","article-title":"Revision rates after endoscopic sinus surgery: a recurrence analysis","volume":"120","author":"Mendelsohn","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2026.07.018_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.23610","article-title":"Role of frontal sinus surgery in nasal polyp recurrence","volume":"123","author":"Bassiouni","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2026.07.018_bib31","first-page":"252","article-title":"Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database","volume":"60","author":"Hopkins","year":"2022","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2026.07.018_bib32","article-title":"Real-world predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps","author":"Dorismond","year":"202515221","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2026.07.018_bib33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.07.018_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.07.018_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.anai.2020.09.011","article-title":"Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease","volume":"126","author":"Cavagnero","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib37","first-page":"482","article-title":"Clinical predictors of polyps recurring in patients with chronic rhinosinusitis and nasal polyps: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2023","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2026.07.018_bib38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4193\/Rhino10.261","article-title":"Mucosal eosinophilia and recurrence of nasal polyps\u2014new classification of chronic rhinosinusitis","volume":"49","author":"Nakayama","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2026.07.018_bib39","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib40","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib41","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jaip.2025.04.043","article-title":"Reappraisal of biologic efficacy from phase 3 trials in refractory chronic rhinosinusitis and nasal polyps","volume":"13","author":"Lipworth","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.018_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.anai.2023.06.017","article-title":"Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth","volume":"131","author":"Supron","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2022.04.007","article-title":"Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease","volume":"150","author":"Buchheit","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib44","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/all.15067","article-title":"Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials","volume":"77","author":"Mullol","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib45","article-title":"Dupilumab treatment for aspirin-exacerbated respiratory disease in a real-world setting: impact on quality of life and healthcare utilization","author":"Mullur","year":"2024","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaci.2024.10.016","article-title":"Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)","volume":"155","author":"Seys","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib47","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2020.11.001","article-title":"Inflammatory heterogeneity in aspirin-exacerbated respiratory disease","volume":"147","author":"Scott","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2024.04.020","article-title":"IL-4Ralpha signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease","volume":"154","author":"Chen","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaip.2022.03.021","article-title":"Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease","volume":"10","author":"Corey","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.018_bib50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2020.04.064","article-title":"Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease","volume":"147","author":"Haimerl","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"131","key":"10.1016\/j.jaci.2026.07.018_bib51","first-page":"56413","article-title":"Absorption of nasal and bronchial fluids: precision sampling of the human respiratory mucosa and laboratory processing of samples","author":"Thwaites","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jaci.2026.07.018_bib52","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41590-022-01312-0","article-title":"Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis","volume":"23","author":"Wang","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2026.07.018_bib54","author":"Marsh"},{"key":"10.1016\/j.jaci.2026.07.018_bib55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/alr.22664","article-title":"Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps","volume":"11","author":"Lu","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2026.07.018_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1061658","article-title":"Exploration of predictive biomarkers for postoperative recurrence in chronic rhinosinusitis with nasal polyps based on serum multiple-cytokine profiling","volume":"2022","author":"Wang","year":"2022","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2026.07.018_bib58","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2008.01885.x","article-title":"Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients","volume":"64","author":"Gevaert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2500\/ajra.2014.28.4024","article-title":"The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study","volume":"28","author":"Vlaminck","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2024.102286","article-title":"Epithelial IL5RA promotes epithelial\u2013mesenchymal transition in pulmonary fibrosis via Jak2\/STAT3 cascade","volume":"84","author":"Chen","year":"2024","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.07.018_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2023.10.011","article-title":"Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease","volume":"153","author":"Sohail","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib62","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1111\/all.16357","article-title":"More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days","volume":"79","author":"Otten","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.14639\/0392-100X-N2717","article-title":"TIM-3\u2013driven macrophage polarisation is associated to recalcitrant chronic rhinosinusitis with nasal polyps","volume":"44","author":"Jiang","year":"2024","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.jaci.2026.07.018_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110449","article-title":"Overexpression of AXL on macrophages associates with disease severity and recurrence in chronic rhinosinusitis with nasal polyps","volume":"121","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2026.07.018_bib65","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaci.2024.04.019","article-title":"ALOX15+ M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"154","author":"Liu","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaci.2025.09.006","article-title":"Resolution of epithelial dysfunction in eosinophilic esophagitis is mediated by an HIF-1alpha\u2013CD73\u2013adenosine signaling axis","volume":"157","author":"Kellett","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jaci.2023.09.020","article-title":"Hypoxia-inducible factor 1alpha activates the NLRP3 inflammasome to regulate epithelial differentiation in chronic rhinosinusitis","volume":"152","author":"Zhong","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.018_bib68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00405-013-2683-x","article-title":"IL-17C expression in nasal epithelial cells of chronic rhinosinusitis with nasal polyposis","volume":"271","author":"Jin","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaci.2026.07.018_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060897","article-title":"Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs","volume":"12","author":"De Corso","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2026.07.018_bib70","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/lary.28152","article-title":"Intranasal corticosteroids and saline: usage and adherence in chronic rhinosinusitis patients","volume":"130","author":"Phillips","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2026.07.018_bib71","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1002\/lary.27112","article-title":"Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis","volume":"128","author":"Wu","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2026.07.018_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2500\/ajra.2013.27.3850","article-title":"A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study","volume":"27","author":"Rank","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2026.07.018_bib73","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2015.01.043","article-title":"Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease","volume":"136","author":"Pothoven","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:36:07Z","timestamp":1793784967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926005610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0091674926005610"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond type 2 inflammation: An innate\u2013myeloid axis is linked to recurrence of chronic rhinosinusitis with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}